<html>
<head>PUBMED IDs for Cyp-D</head>
<body bgcolor='#C5F0F2'><h1>Cyp-D</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19293339/'>Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice.</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23845906/'>Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling.</a> October 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23845903/'>Estrogen induced concentration dependent differential gene expression in human breast cancer (MCF7) cells: role of transcription factors.</a> October 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24732633/'>Gemcitabine-induced pancreatic cancer cell death is associated with MST1/cyclophilin D mitochondrial complexation.</a> February 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25201730/'>Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.</a> February 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25837584/'>Cyclophilin-D: a resident regulator of mitochondrial gene expression.</a> September 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26084607/'>Targeting pancreatic cancer cells by a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595.</a> March 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27311860/'>mTOR inhibition sensitizes human hepatocellular carcinoma cells to resminostat.</a> May 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27658776/'>The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo.</a> September 24  2016<br></body></html>
